Achilles Therapeutics PLC - ESG Rating & Company Profile powered by AI
The SDG assessment for Achilles Therapeutics PLC indicates the company's transparency towards the United Nations SDGs. This report of Achilles Therapeutics PLC incorporates information from across the internet as well as from public filings by Achilles Therapeutics PLC. Check the bottom of this page for potential risks for Achilles Therapeutics PLC based on sector, location and size.
Achilles Therapeutics PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.5; made up of an environmental score of 0.0, social score of 1.3 and governance score of 0.0.
0.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2628 | Orient Europharma Co Ltd | 0.7 | Low |
| 2628 | Shandong Jintai Group Co Ltd | 0.7 | Low |
| 2634 | Achilles Therapeutics PLC | 0.5 | Low |
| 2634 | American Green Inc | 0.5 | Low |
| 2634 | Arrayit Corp | 0.5 | Low |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Achilles Therapeutics PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Achilles Therapeutics PLC report the average age of the workforce?
Sign up for free to unlockDoes Achilles Therapeutics PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Achilles Therapeutics PLC offer flexible work?
Sign up for free to unlockDoes Achilles Therapeutics PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Achilles Therapeutics PLC conduct supply chain audits?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Achilles Therapeutics PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose water use targets?
Sign up for free to unlockDoes Achilles Therapeutics PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Achilles Therapeutics PLC have a product recall in the last two years?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Achilles Therapeutics PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Achilles Therapeutics PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose parental leave metrics?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Achilles Therapeutics PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Achilles Therapeutics PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Achilles Therapeutics PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose its waste policy?
Sign up for free to unlockDoes Achilles Therapeutics PLC report according to TCFD requirements?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose energy use targets?
Sign up for free to unlockDoes Achilles Therapeutics PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Achilles Therapeutics PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Achilles Therapeutics PLC
These potential risks are based on the size, segment and geographies of the company.
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. The company was founded in 2016 and is headquartered in London, the United Kingdom.